Pasar al contenido principal

DESCIFRANDO LOS MECANISMOS MOLECULARES REGULADOS POR EL COMPLEJO BAP1 PR-DUB DE INVASION CELULAR COMPARTIDOS ENTRE EL TROFOBLASTO HUMANO Y LAS CELULAS CANCEROSAS

PID2020-114459RA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIÓN DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRÍNCIPE FELIPE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PI3Kβ-regulated β-catenin mediates EZH2 removal from promoters controlling primed human ESC stemness and primitive streak gene expression

  • Yadav, Sudhanshu
  • Garrido, Antonio
  • Hernández, M. Carmen
  • Oliveros, Juan C.
  • Pérez-García, Vicente
  • Fraga, Mario F.
  • Carrera, Ana C.
The mechanism governing the transition of human embryonic stem cells (hESCs) toward differentiated cells is only partially understood. To explore this transition, the activity and expression of the ubiquitous phosphatidylinositol 3-kinase (PI3Kα and PI3Kβ) were modulated in primed hESCs. The study reports a pathway that dismantles the restraint imposed by the EZH2 polycomb repressor on an essential stemness gene, NODAL, and on transcription factors required to trigger primitive streak formation. The primitive streak is the site where gastrulation begins to give rise to the three embryonic cell layers from which all human tissues derive. The pathway involves a PI3Kβ non-catalytic action that controls nuclear/active RAC1 levels, activation of JNK (Jun N-terminal kinase) and nuclear β-catenin accumulation. β-Catenin deposition at promoters triggers release of the EZH2 repressor, permitting stemness maintenance (through control of NODAL) and correct differentiation by allowing primitive streak master gene expression. PI3Kβ epigenetic control of EZH2/β-catenin might be modulated to direct stem cell differentiation., This work was funded by the Spanish Ministry of Science, Innovation and Universities (SAF2016-79195-R and PID2019-106937RB-I00), by the Madrid Regional Government (S2017/BMD-3804), and by the Spanish Association Against Cancer (16035CARR). V.P.-G. was supported by the Spanish Ministry of Science and Innovation (RYC-2019-026956 and PID2020-114459RA-I00).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Reduced Levels of miR-145-3p Drive Cell Cycle Progression in Advanced High-Grade Serous Ovarian Cancer

  • González-Cantó, Eva
  • Monteiro, Mariana
  • Aghababyan, Cristina
  • Ferrero-Micó, Ana
  • Navarro-Serna, Sergio
  • Mellado-López, Maravillas
  • Tomás-Pérez, Sarai
  • Sandoval, Juan
  • Llueca, Antoni
  • Herreros-Pomares, Alejandro
  • Gilabert-Estellés, Juan
  • Pérez-García, Vicente
  • Marí-Alexandre, Josep
High-grade serous ovarian cancer (HGSOC) is the most lethal form of gynecologic cancer, with limited treatment options and a poor prognosis. Epigenetic factors, such as microRNAs (miRNAs) and DNA methylation, play pivotal roles in cancer progression, yet their specific contributions to HGSOC remain insufficiently understood. In this study, we performed comprehensive high-throughput analyses to identify dysregulated miRNAs in HGSOC and investigate their epigenetic regulation. Analysis of tissue samples from advanced-stage HGSOC patients revealed 20 differentially expressed miRNAs, 11 of which were corroborated via RT-qPCR in patient samples and cancer cell lines. Among these, miR-145-3p was consistently downregulated post-neoadjuvant therapy and was able to distinguish tumoural from control tissues. Further investigation confirmed that DNA methylation controls MIR145 expression. Functional assays showed that overexpression of miR-145-3p significantly reduced cell migration and induced G0/G1 cell cycle arrest by modulating the cyclin D1-CDK4/6 pathway. These findings suggest that miR-145-3p downregulation enhances cell proliferation and motility in HGSOC, implicating its restoration as a potential therapeutic target focused on G1/S phase regulation in the treatment of HGSOC., This research was funded by the “Instituto de Salud Carlos III Fondo Europeo de Desarrollo Regional” (ISCIII-FEDER), Spain (PI17/01945 and PI22/01872), the “Generalitat Valenciana”, Spain (GV/2020/200), the “Sociedad de Obstetricia y Ginecología de la Comunidad Valenciana” (SOGCV), Spain (Prize SOGCV 2019), the “Fundación para la Investigación del Hospital General Universitario de Valencia” (FIHGUV), Spain (Prize FIHGUV 2019 and 2023), and Amunt Contra el Càncer (patients’ non-profit association; Denia, Spain). E.G.-C. is supported by a pre-doctoral grant from the “Generalitat Valenciana” (ACIF/2020/216); A.F.-M. and S.T.-P. are supported by pre-doctoral grants from the “Junta Asociada Provincial de Valencia de la Asociación Española Contra el Cáncer (AECC)”; J.S. is supported by the Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación (PID2022-137965OB-I00); V.P.-G. is supported by the Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación MICIU/AEI/10.13039/501100011033, and by ESF investing in your future (CNS2022-135933, PID2020-114459RA-I00 and PLEC2022-009246) and Fundación Ramón Areces., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fetal growth restriction and placental defects in obese mice are associated with impaired decidualisation: the role of increased leptin signalling modulators SOCS3 and PTPN2

  • Walewska, Edyta
  • Makowczenko, Karol G.
  • Witek, Krzysztof
  • Laniecka, Elżbieta
  • Molcan, Tomasz
  • Alvarez-Sanchez, Andrea
  • Kelsey, Gavin
  • Perez-Garcia, Vicente
  • Galvão, António M.
Decidualisation of the endometrium is a key event in early pregnancy, which enables embryo implantation. Importantly, the molecular processes impairing decidualisation in obese mothers are yet to be characterised. We hypothesise that impaired decidualisation in obese mice is mediated by the upregulation of leptin modulators, the suppressor of cytokine signalling 3 (SOCS3) and the protein tyrosine phosphatase non-receptor type 2 (PTPN2), together with the disruption of progesterone (P4)-signal transducer and activator of transcription (STAT3) signalling. After feeding mice with chow diet (CD) or high-fat diet (HFD) for 16 weeks, we confirmed the downregulation of P4 and oestradiol (E2) steroid receptors in decidua from embryonic day (E) 6.5 and decreased proliferation of stromal cells from HFD. In vitro decidualised mouse endometrial stromal cells (MESCs) and E6.5 deciduas from the HFD showed decreased expression of decidualisation markers, followed by the upregulation of SOCS3 and PTPN2 and decreased phosphorylation of STAT3. In vivo and in vitro leptin treatment of mice and MESCs mimicked the results observed in the obese model. The downregulation of Socs3 and Ptpn2 after siRNA transfection of MESCs from HFD mice restored the expression level of decidualisation markers. Finally, DIO mice placentas from E18.5 showed decreased labyrinth development and vascularisation and fetal growth restricted embryos. The present study revealed major defects in decidualisation in obese mice, characterised by altered uterine response to E2 and P4 steroid signalling. Importantly, altered hormonal response was associated with increased expression of leptin signalling modulators SOCS3 and PTPN2. Elevated levels of SOCS3 and PTPN2 were shown to molecularly affect decidualisation in obese mice, potentially disrupting the STAT3-PR regulatory molecular hub., Funding Work in A.G.’s lab supported by the Grant (2019/34/E/NZ4/00349) from the Polish National Science Centre; E.W. was supported by the Grant (2019/35/N/NZ4/03496) from the Polish National Science Centre; E.W. was supported by The Polish National Agency For Academic Exchange Research Fellowship (NAWA Prom, PPI/PRO/2019/1/00042/U/0001) and by the Polish Society of Reproductive Biology Research Fellowship. G.K. was supported by the UK Biotechnology and Biological Sciences Research Council (BBS/E/B/000C0423) and Medical Research Council (MR/S000437/1). V.P-G is supported by the Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación (RYC-2019-026956, PID2020-114459RA-I00/AEI/10.&&&&13039/501100011033 and PLEC2022-009246) and Fundación Ramón Areces. Part of the equipment employed in this work was funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014–2020).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The GPI-anchor biosynthesis pathway is critical for syncytiotrophoblast differentiation and placental development

  • Álvarez-Sánchez, Andrea
  • Grinat, Johanna
  • Doria-Borrell, Paula
  • Mellado-López, Maravillas
  • Pedrera-Alcócer, Érica
  • Malenchini, Marta
  • Meseguer, Salvador
  • Hemberger, Myriam
  • Pérez-García, Vicente
The glycosylphosphatidylinositol (GPI) biosynthetic pathway in the endoplasmic reticulum (ER) is crucial for generating GPI-anchored proteins (GPI-APs), which are translocated to the cell surface and play a vital role in cell signaling and adhesion. This study focuses on two integral components of the GPI pathway, the PIGL and PIGF proteins, and their significance in trophoblast biology. We show that GPI pathway mutations impact on placental development impairing the differentiation of the syncytiotrophoblast (SynT), and especially the SynT-II layer, which is essential for the establishment of the definitive nutrient exchange area within the placental labyrinth. CRISPR/Cas9 knockout of Pigl and Pigf in mouse trophoblast stem cells (mTSCs) confirms the role of these GPI enzymes in syncytiotrophoblast differentiation. Mechanistically, impaired GPI-AP generation induces an excessive unfolded protein response (UPR) in the ER in mTSCs growing in stem cell conditions, akin to what is observed in human preeclampsia. Upon differentiation, the impairment of the GPI pathway hinders the induction of WNT signaling for early SynT-II development. Remarkably, the transcriptomic profile of Pigl- and Pigf-deficient cells separates human patient placental samples into preeclampsia and control groups, suggesting an involvement of Pigl and Pigf in establishing a preeclamptic gene signature. Our study unveils the pivotal role of GPI biosynthesis in early placentation and uncovers a new preeclampsia gene expression profile associated with mutations in the GPI biosynthesis pathway, providing novel molecular insights into placental development with implications for enhanced patient stratification and timely interventions., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación, RYC-2019-026956, Vicente PérezGarcía, Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación, PID2020-114459RA-I00/AEI/10.13039/501100011033, Vicente Pérez-García, Spanish National Plan for Scientific and Technical Research and Innovation, PLEC2022-009246/MCIN/AEI/10.13039/501100011033, Vicente Pérez-García, Fundación Ramón Areces, FRA-VPG, Vicente Pérez-García, Canada Excellence Research Chairs, Government of Canada, Tier I, Myriam Hemberger
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Understanding the intersection between placental development and cancer: Lessons from the tumor suppressor BAP1

  • Doria-Borrell, Paula
  • Pérez-García, Vicente
The placenta, a pivotal organ in mammalian reproduction, allows nutrient exchange and hormonal signaling between the mother and the developing fetus. Understanding its molecular intricacies is essential for deciphering normal embryonic development and pathological conditions such as tumorigenesis. Here, we explore the multifaceted role of the tumor suppressor BRCA1-associated protein 1 (BAP1) in cancer and placentation. Initially recognized for its tumor-suppressive properties, BAP1 has emerged as a key regulator at the intersection of tumorigenesis and placental development. BAP1 influences crucial cellular processes such as cell death, proliferation, metabolism, and response to hypoxic conditions. By integrating insights from tumor and developmental biology, we illuminate the complex molecular pathways orchestrated by BAP1. This perspective highlights BAP1's significant impact on both cancer and placental development, and suggests novel therapeutic strategies that could improve outcomes for pregnancy disorders and cancer., This work was supported by the Fundación Ramón Areces and the grants RYC2019-026956-I and PID2020-114459RA-I00, funded by the MICIU/AEI/10.13039/501100011033, and by ESF investing in your future.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

BAP1 dysregulation impairs trophoblast differentiation and contributes to placental dysfunction in preeclampsia

  • Doria-Borrell, Paula
  • Ferrero-Micó, Ana
  • Navarro-Serna, Sergio
  • Mellado-López, Maravillas
  • Grinat, Johanna
  • Murphy, Ciara N.
  • Youssef, Lina
  • Youssef, Lina
  • J Kaitu’u-Lino, Tu’uhevaha
  • Pérez-García, Vicente
Preeclampsia, a life-threatening hypertensive disorder of pregnancy, is a leading cause of maternal and perinatal morbidity and mortality. Its early-onset form (EO-PE), requiring delivery before 34 weeks of gestation, is particularly severe and closely linked to defective trophoblast differentiation. Here, we identify BRCA1-associated protein 1 (BAP1) and its cofactors ASXL2 and ASXL3 as upregulated in EO-PE placentas. Enforced BAP1 expression in human trophoblast stem cells reinforced epithelial identity, enhanced adhesion, and impaired both extravillous trophoblast differentiation and syncytiotrophoblast formation. Integrated transcriptomic and proteomic analyses revealed suppression of lineage-specific pathways alongside maintenance of progenitor-like and pro-inflammatory signatures. In trophoblast organoids, an excess of BAP1 disrupted syncytial maturation and induced interferon-driven pathways overlapping with EO-PE transcriptomes. Together, these findings establish BAP1 as a key regulator of human trophoblast differentiation and implicate its dysregulation in the pathogenesis of EO-PE, providing mechanistic insight into the cellular basis of placental dysfunction., This work was funded by the Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación (MICIU/AEI/10.13039/501100011033), under grant numbers PID2020-114459RA-I00, PID2023-148535OB-I00, and CNS2022-135933, as well as by the Fundación Ramón Areces. AF-M is supported by a PhD fellowship from the Asociación Española Contra el Cáncer (AECC) – Comunitat Valenciana. LY was supported by the BITRECS fellowship programme (“Biomedicine International Training Research Programme for Excellent Clinician-Scientist”) at Hospital Clínic de Barcelona, funded by the “la Caixa” Foundation (grant code LCF/PR/SP23/52950012). FC received support from Hospital Clínic de Barcelona (Intensificació Interna) and the Fundació Jesús Serra of the Grup Catalana Occident.